Literature DB >> 17212573

Acquired long QT syndrome secondary to cesium chloride supplement.

Himeshkumar Vyas1, Katya Johnson, Robert Houlihan, Brent A Bauer, Michael J Ackerman.   

Abstract

The use of complementary medication is on the rise worldwide. More often than not, the treating physicians are unaware of this and also unfamiliar with the potential benefit or toxicity of the agents. Here, we present the case of a 39-year-old woman who presented with new onset of syncope as a result of acquired long QT syndrome secondary to taking a cesium chloride supplement. A brief discussion of the pathophysiology of this agent follows the case presentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17212573     DOI: 10.1089/acm.2006.12.1011

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  3 in total

1.  Fatal cesium chloride toxicity after alternative cancer treatment.

Authors:  Daniel Sessions; Kennon Heard; Michael Kosnett
Journal:  J Altern Complement Med       Date:  2013-07-10       Impact factor: 2.579

2.  Cesium-associated hypokalemia successfully treated with amiloride.

Authors:  Sarah Horn; Elliot Naidus; Seth L Alper; John Danziger
Journal:  Clin Kidney J       Date:  2015-03-31

Review 3.  Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives.

Authors:  Jialin Duan; Jingwen Tao; Maocai Zhai; Chengpeng Li; Ning Zhou; Jiagao Lv; Lin Wang; Li Lin; Rong Bai
Journal:  Oncotarget       Date:  2018-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.